{"url_path":"/sec/zura/8-k/2026-08-11/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1855644/0001855644-26-000007-index.html","accession_number":"0001855644-26-000007","cik":"0001855644","ticker":"ZURA","issuer_name":"Zura Bio Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855644/0001855644-26-000007-index.html","primary_entity_key":"0001855644","primary_entity_name":"Zura Bio Ltd"},"word_count":163,"has_tables":true,"body_markdown":"Item 7.01.    Regulation FD Disclosure.\n\nOn August 11, 2026, the Company provided an updated corporate presentation that may be used in connection with upcoming presentations at conferences and investor meetings. The full text of the Company’s corporate presentation is filed as Exhibit 99.2 hereto, and incorporated herein by reference, and may also be accessed through the “News & Events” section of the Company’s website at investors.zurabio.com.\n\nThe information furnished under this Item 7.01 (including Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act. The information in this Item 7.01 (including Exhibit 99.2) shall not be deemed incorporated by reference into any other filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such a filing."}